A

ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd
SZSE:301234

Watchlist Manager
ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd
SZSE:301234
Watchlist
Price: 38.81 CNY -3.14% Market Closed
Market Cap: ¥1.7B

Wall Street
Price Targets

Price Targets Summary
ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd

There are no price targets for ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd Competitors:
Price Targets
VRTX
Vertex Pharmaceuticals Inc
18% Upside
XLO
Xilio Therapeutics Inc
296% Upside

Revenue
Forecast

0% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
0% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Revenue forecast
is not available for
ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd

Operating Income
Forecast

-16% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-16% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd

Net Income
Forecast

-8% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-8% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Net Income forecast
is not available for
ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd's stock price target?
Not Available

ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd doesn't have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett